Literature DB >> 31823317

Retrospective Comparison of Endoscopic Full-Thickness Versus Laparoscopic or Surgical Resection of Small (≤ 5 cm) Gastric Gastrointestinal Stromal Tumors.

Yan Zhao1,2, Taohong Pang3,4, Bin Zhang3, Lei Wang3, Ying Lv3, Tingsheng Ling3, Xiaoqi Zhang3, Qin Huang5,6, Guifang Xu7, Xiaoping Zou8,9.   

Abstract

AIM AND
BACKGROUND: The aim of this study was to compare the efficacy and safety between endoscopic full-thickness resection (EFR) and laparoscopic or surgical resection methods for gastric gastrointestinal stromal tumor (GIST) in size of 5.0 cm or less. Gastric GISTs are common, and resection is the most effective treatment.
METHOD: We retrospectively reviewed 216 resections of gastric GISTs in size of up to 5.0 cm at our center from 2009 to 2017.Eligible resection cases were divided into EFR (n = 85), laparoscopic(n = 64), and surgical (n = 67) groups. The clinical records, patient demographic, symptoms, perioperative data, pathological findings, and long-term follow-up outcomes were collected and compared statistically.
RESULTS: No tumor rupture or recurrence occurred in the three groups. The prevalence of complications was significantly lower in EFR (5.9%) than both laparoscopic (7.8%) and surgical group (16.4%) (P < 0.01). In EFR group, the R0 resection rate (95.3%) was significantly lower than in the laparoscopic group and surgical group (100%) (P < 0.001). The hospital cost (OR = 62.79, CI: 12.954-304.363, P < 0.0001) were significantly lower in the EFR than in the laparoscopic group. The hospital cost (OR = 39.032, CI: 8.045-189.371, P < 0.0001) and post-operative diet time (OR = 2.779, CI: 1.225-6.304, P < 0.05) were also significantly lower in the EFR than in the surgical group.
CONCLUSION: EFR was a feasible treatment for gastric GISTs of size of ≤ 5.0 cm with an acceptable complete resection rate. In addition, EFR had significantly fewer postoperative complications, shorter length of hospital stay, and lower cost.

Entities:  

Keywords:  Endoscopic full-thickness resection; Gastrointestinal stromal tumor; Laparoscopic surgery; Stomach

Mesh:

Year:  2019        PMID: 31823317     DOI: 10.1007/s11605-019-04493-6

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  1 in total

1.  Endoscopic full-thickness resection of esophagogastric junction gastrointestinal stromal tumor assisted by laparoscopy after neoadjuvant therapy.

Authors:  Andrés Navarrete; Dulce Momblan; Gloria Fernandez-Esparrach; Salvadora Delgado; Marta Jimenez; Amelia Hessheimer; Antonio M Lacy
Journal:  Endoscopy       Date:  2016-03-23       Impact factor: 10.093

  1 in total
  4 in total

1.  Long-term prognosis of small gastric gastrointestinal stromal tumors with high histological grade: a longitudinal nested cohort study.

Authors:  Tian-Yin Chen; Jia-Xin Xu; Wei-Feng Chen; Quan-Lin Li; Ming-Yan Cai; Jian-Wei Hu; Wen-Zheng Qin; Yuan Ji; Xiao-Yue Xu; Yi-Qun Zhang; Ping-Hong Zhou
Journal:  Surg Endosc       Date:  2022-02-08       Impact factor: 3.453

2.  Accreditation as a qualified surgeon improves surgical outcomes in laparoscopic distal gastrectomy.

Authors:  Satoru Kikuchi; Tetsuya Kagawa; Shinji Kuroda; Masahiko Nishizaki; Nobuo Takata; Kazuya Kuwada; Ryohei Shoji; Yoshihiko Kakiuchi; Toshiharu Mitsuhashi; Yuzo Umeda; Kazuhiro Noma; Shunsuke Kagawa; Toshiyoshi Fujiwara
Journal:  Surg Today       Date:  2021-05-29       Impact factor: 2.549

3.  Comparison Among Endoscopic, Laparoscopic, and Open Resection for Relatively Small Gastric Gastrointestinal Stromal Tumors (<5 cm): A Bayesian Network Meta-Analysis.

Authors:  Zhen Liu; Ziyang Zeng; Siwen Ouyang; Zimu Zhang; Juan Sun; Xianze Wang; Xin Ye; Weiming Kang; Jianchun Yu
Journal:  Front Oncol       Date:  2021-11-29       Impact factor: 6.244

4.  Surgical Resection Is Still Better Than Endoscopic Resection for Patients With 2-5 cm Gastric Gastrointestinal Stromal Tumours: A Propensity Score Matching Analysis.

Authors:  Hao Wu; Han Li; Qinfeng Xu; Liang Shang; Ronghua Zhang; Chen Li; Mengdi Fu; Wandi Xu; Jianfeng Chen; Jin Liu; Leping Li
Journal:  Front Oncol       Date:  2021-09-15       Impact factor: 6.244

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.